TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Uses AI to: Process raw phenotypic, imaging, drug, and genomic data sets. Allows researchers to: Integrate rapid analytics and machine learning capabilities into existing business processes to improve care, enhance discoveries, gain insight into business, and enable fast data-driven decisions.
This report contains market size and forecasts of Artificial Intelligence (AI) in Drug Discovery in Global, including the following market information:
The global Artificial Intelligence (AI) in Drug Discovery market was valued at 780.2 million in 2021 and is projected to reach US$ 3053.7 million by 2028, at a CAGR of 21.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Software Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence (AI) in Drug Discovery include IBM, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine and BenevolentAI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Intelligence (AI) in Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence (AI) in Drug Discovery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence (AI) in Drug Discovery Market Segment Percentages, by Type, 2021 (%)
